Instrument Inactif

Autres langues Wintac Limited

Actions

524758

INE812C01016

Produits pharmaceutiques

Autres langues

10/08/23	Somerset Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023
11/08/22	Wintac Limited Reports Earnings Results for the Full Year Ended March 31, 2022
12/11/20	Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
24/09/20	Wintac : Clearent acquires Wintac to expand field-service management software solutions
07/08/20	Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
22/06/20	Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
04/02/20	Wintac Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019
04/02/20	Wintac Limited Appoints S. Nanthitha as Additional Director
27/01/20	Wintac Limited Announces Resignation of Ms. K. M. Ganga as Independent Director
13/11/19	Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019
12/08/19	Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
23/05/19	Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
27/02/19	Par Formulations Pvt Ltd cancelled the acquisition of Pharmaceutical Business from Wintac Limited.
11/02/19	Wintac Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2018
12/11/18	Wintac Ltd Announces Unaudited Standalone Financial Results for the Second Quarter and Six Months Ended September 30, 2018
07/08/18	Wintac Ltd. Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018
29/05/18	Wintac Limited Announces Resignation of B. R. Arun Eashwar as Independent Director
23/05/18	Wintac Limited Announces Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2018
23/05/18	Wintac Limited Appoints R.A.Thirumoorti as Additional Director
26/04/18	Par Formulations Pvt Ltd agreed to acquire Pharmaceutical Business from Wintac Limited for $15.3 million.
23/04/18	VEEGO PHARMA, LLC made a proposal to acquire remaining 45% stake in Wintac Limited from public shareholders for approximately INR 990 million.
10/02/18	Wintac Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
06/12/17	Wintac Ltd Announces Unaudited Standalone Financial Results for the Second Quarter and Six Months Ended September 30, 2017
11/09/17	Wintac Ltd. Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2017
11/08/17	Wintac Limited Announces the Resignation of Independent Directors